Skip to main content
Signal8

Jung Melita Sun

SEC insider (Form 3/4/5 filer). CIK 0001962407. Chief Business Officer at Terns Pharmaceuticals, Inc. (TERN). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2025. Located in FOSTER CITY, CA.

Companies Jung Melita Sun has filed insider reports for

  • Terns Pharmaceuticals, Inc. (TERN): Officer, Chief Business Officer
Jung Melita Sun profile photo

Jung Melita Sun

CIK: 0001962407

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Terns Pharmaceuticals, Inc. logo
TERN

Terns Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    Jan 30, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    325K shares-
  • Terns Pharmaceuticals, Inc. logo
    TERN

    Terns Pharmaceuticals, Inc.

    Nov 30, 2024
    Purchase
    Direct
    2.3K shares at avg. $5.11$11K

1-2 of 2